Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Itaconix plc (ITXXF)
Stratham, NH, US
Itaconix plc, in conjunction with its various subsidiary operations, focuses on the creation, manufacturing, and commercialization of polymers derived from biological sources. These materials are supplied to the personal care, domestic cleaning, and industrial markets across both North America and Europe. The company's offerings for household and industrial applications encompass a selection of water-soluble polymers, such as Itaconix TSI 322, Itaconix DSP 2K, Itaconix TSI 122, and Itaconix VELASOFT. Additionally, they provide water-soluble odor neutralizers under the names Itaconix ZINADOR 22L and 35L. For personal care products, Itaconix provides water-soluble fixating complexes, specifically Itaconix VELAFRESH ZP20 and ZP30. Their portfolio also includes Nouryon Amaze SP, an active ingredient used in hair styling formulations. Established in 2012, the organization was initially known as Revolymer plc, later adopting the name Itaconix plc in February 2017. Its primary corporate office is located in Stratham, New Hampshire.
6 articles
- Helen of Troy reports surprise profit, raises revenue outlook Proactive Investors - Finance
- Itaconix extends detergent tablet partnership with Bonals to 2028 Proactive Investors
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +23.33% | +23.33% | -7.50% | -7.50% | -32.73% | -37.02% | -85.94% | +169.09% | +169.09% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals - Specialty: +4.7%+64.8% ★ Q4'25: +198.4% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%+28.7% ★ Q4'25: -122.5% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-11.5% Q4'25: -17.0% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%-9.9% Q4'25: -10.6% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%-18.1% Q4'25: -41.2% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q4'25: +4.5% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-1.91× Q4'25: -0.84× (vs Q4'23)
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.85M
est: 2.62M (-29.3%)
|
351.6K
est: 455.0K (-22.7%)
|
747.3K
est: 1.09M (-31.5%)
|
837.5K
est: 1.37M (-38.8%)
|
972.3K
est: 1.87M (-47.9%)
|
3.29M
est: 5.58M (-41.0%)
|
2.60M
est: 3.51M (-26.0%)
|
5.60M
est: 6.77M (-17.3%)
|
7.87M
est: 9.99M (-21.2%)
|
6.50M
est: 6.60M (-1.5%)
|
10.72M
est: 10.33M (+3.8%)
|
13.34M
13.34M – 13.34M
+29.2% YoY
|
15.52M
15.52M – 15.52M
+16.3% YoY
|
| EBITDA |
-3.63M
est: -878.8K (-313.0%)
|
-4.80M
est: -152.8K (-3,039.3%)
|
-4.65M
est: -366.5K (-1,168.3%)
|
-5.37M
est: -459.7K (-1,068.3%)
|
-1.98M
est: -627.3K (-215.6%)
|
-1.01M
est: -1.87M (+45.9%)
|
-1.66M
est: -1.18M (-40.8%)
|
-2.05M
est: -2.27M (+9.6%)
|
-1.03M
est: -3.35M (+69.2%)
|
-1.52M
est: -1.94M (+21.7%)
|
-1.06M
est: -3.04M (+65.0%)
|
-3.92M
-3.92M – -3.92M
-29.2% YoY
|
-4.57M
-4.57M – -4.57M
-16.3% YoY
|
| EBIT |
-3.87M
est: -1.10M (-250.7%)
|
-6.39M
est: -191.7K (-3,234.9%)
|
-6.99M
est: -459.8K (-1,420.7%)
|
-5.67M
est: -576.7K (-882.5%)
|
-2.15M
est: -787.1K (-173.0%)
|
-1.41M
est: -2.35M (+40.0%)
|
-2.03M
est: -1.48M (-37.1%)
|
-2.41M
est: -2.85M (+15.5%)
|
-1.43M
est: -4.21M (+66.0%)
|
-1.85M
est: -2.35M (+21.0%)
|
-1.06M
est: -3.67M (+71.1%)
|
-4.74M
-4.74M – -4.74M
-29.2% YoY
|
-5.52M
-5.52M – -5.52M
-16.3% YoY
|
| Net Income |
-2.65M
est: -40.43M (+93.4%)
|
-7.05M
est: -34.24M (+79.4%)
|
-13.70M
est: -38.26M (+64.2%)
|
-9.21M
est: -23.78M (+61.3%)
|
-1.03M
est: -7.32M (+86.0%)
|
-1.65M
est: -5.00M (+67.1%)
|
-455.0K
est: -2.80M (+83.7%)
|
-2.46M
est: -2.65M (+7.1%)
|
-1.54M
est: -1.29M (-19.2%)
|
-1.87M
est: -1.86M (-0.3%)
|
-1.41M
est: -891.1K (-58.1%)
|
-43.8K
-43.8K – -43.8K
+95.1% YoY
|
311.4K
311.4K – 311.4K
+810.7% YoY
|
| SGA |
5.61M
est: 1.98M (+183.6%)
|
6.51M
est: 343.9K (+1,792.7%)
|
7.44M
est: 824.7K (+802.4%)
|
5.47M
est: 1.03M (+428.7%)
|
2.48M
est: 1.41M (+75.9%)
|
2.60M
est: 4.22M (-38.4%)
|
2.91M
est: 2.65M (+9.8%)
|
3.80M
est: 5.12M (-25.7%)
|
3.99M
est: 7.55M (-47.2%)
|
4.44M
est: 4.54M (-2.1%)
|
4.78M
est: 7.10M (-32.7%)
|
9.17M
9.17M – 9.17M
+29.2% YoY
|
10.67M
10.67M – 10.67M
+16.3% YoY
|
| EPS |
-0.03
est: -3.00 (+98.9%)
|
-0.07
est: -2.54 (+97.1%)
|
-0.10
est: -2.84 (+96.5%)
|
-0.06
est: -1.76 (+96.7%)
|
-0.19
est: -0.54 (+65.0%)
|
-0.25
est: -0.37 (+32.5%)
|
-0.05
est: -0.21 (+75.4%)
|
-0.23
est: -0.20 (-17.0%)
|
-0.12
est: -0.10 (-25.6%)
|
-0.14
est: -0.14 (-1.5%)
|
-0.10
est: -0.07 (-51.0%)
|
0.00
0.00 – 0.00
+95.1% YoY
|
0.02
0.02 – 0.02
+810.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| John Roger Shaw | Co-Founder, Chief Executive Officer & Director | 315.0K | male |
| Laura Elizabeth Denner | Chief Financial Officer, Company Secretary & Executive Director | 271.0K | female |
| John Pelech | Vice President of Operations | — | — |
| Yvon G. Durant | Co-Founder & Chief Technology Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ITXXF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
